- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07582913
Manual Versus Autoflow Ventilation During Anesthesia Inductıon in Geriatric Patients
Effects of Manual Versus Autoflow Ventilation During Anesthesia Induction on Cerebral and Peripheral Oxygenation in Geriatric Patients
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Ventilation strategies applied during the induction of general anesthesia have a significant impact on cerebral and peripheral oxygenation in geriatric patients. During the induction phase, respiratory and hemodynamic changes become more pronounced due to age-related physiological alterations such as diminished cardiopulmonary reserve, increased chest wall rigidity, decreased pulmonary elasticity, and impaired cerebral autoregulation. These changes increase the vulnerability of elderly patients to hypoxemia, hypocapnia, and imbalances in oxygen delivery. In particular, even brief episodes of hypoxemia or hypocapnia during induction may adversely affect cerebral oxygenation in this population.
Manual mask ventilation may result in unintentional hyperventilation or hypoventilation, potentially leading to hypocapnia and subsequent disturbances in cerebral oxygenation. In contrast, AutoFlow ventilation provides controlled ventilation with predefined parameters and may ensure more stable oxygen delivery.
This study is designed as a prospective, single-center, randomized controlled trial to compare the effects of manual ventilation and AutoFlow ventilation applied during the induction of general anesthesia on cerebral regional oxygen saturation (s-rSO₂) and peripheral (somatic) regional oxygen saturation (p-rSO₂) in geriatric patients. The primary hypothesis is that AutoFlow ventilation provides more stable cerebral and peripheral oxygenation compared to manual ventilation during the induction period.
The study will be conducted in the General and Oncology Operating Rooms of Ankara Bilkent City Hospital. Patients aged 65 years and older, of both sexes, classified as American Society of Anesthesiologists (ASA) physical status I-III, and scheduled for elective surgery requiring endotracheal intubation under general anesthesia will be included. A total of 106 patients (53 per group) will be enrolled based on power analysis, accounting for a potential 10% data loss.
Upon arrival in the operating room following standard preoperative fasting, demographic data (age, sex, height, weight, body mass index) and clinical characteristics (comorbidities, ASA classification) will be recorded. Standard ASA monitoring, including electrocardiography, non-invasive blood pressure, and pulse oximetry, will be applied. Cerebral and peripheral oxygenation will be continuously monitored using near-infrared spectroscopy (NIRS) with sensors placed bilaterally on the frontal region and on the volar surface of the forearms. Baseline values will be recorded before preoxygenation (T1).
Preoxygenation will be performed using 100% oxygen with a flow rate of 10 L/min until end-tidal oxygen (ETO₂) reaches 85% and plateaus for at least 30 seconds. Measurements at this stage will be recorded as T2.
Anesthesia induction will be standardized using fentanyl (1 µg/kg), lidocaine (1 mg/kg), propofol (2-3 mg/kg), and rocuronium (0.6-1 mg/kg), while maintaining hemodynamic stability within ±20% of baseline values. Following induction, mask ventilation with 100% oxygen will be applied for 2 minutes.
Patients will be randomly assigned using a computer-based block randomization method into two groups: manual ventilation and AutoFlow ventilation. In the manual ventilation group, ventilation will be performed by an experienced anesthesiologist or anesthesia resident using a reservoir bag. In the AutoFlow group, ventilation will be delivered by the anesthesia machine using predefined settings: tidal volume of 6 mL/kg (ideal body weight), respiratory rate of 12 breaths per minute, peak pressure limit of 30 cmH₂O, and positive end-expiratory pressure (PEEP) of 5 cmH₂O.
At the end of the 2-minute ventilation period before laryngoscopy, measurements will be recorded as T3 (post-induction, pre-intubation), including heart rate, mean arterial pressure, s-rSO₂, p-rSO₂, end-tidal carbon dioxide (EtCO₂), and peak inspiratory pressure (PIP). After endotracheal intubation and confirmation of tube placement, mechanical ventilation will be initiated and final measurements will be recorded as T4 (post-intubation).
To ensure standardization, NIRS device settings, including alarm limits, noise-reduction filters, and averaging time (8 seconds), will be kept constant for all patients. Factors that may affect measurements, such as motion artifacts, extremity temperature, arrhythmias, or vasopressor use, will be recorded.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: FATMA G KILIÇASLAN, Resident
- Número de teléfono: +905305692877
- Correo electrónico: fatmagulgunkilicaslan@gmail.com
Ubicaciones de estudio
-
-
Çankaya
-
Ankara, Çankaya, Turquía (Türkiye), 06800
- Reclutamiento
- Ankara Bilkent City Hospital Department of Anesthesiology and Reanimation
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Patients aged 65 years and older.
- Patients scheduled to undergo elective surgery requiring endotracheal intubation under general anesthesia.
- Patients with an American Society of Anesthesiologists (ASA) physical status of I, II, or III.
- Volunteer patients who are willing to participate and provide written informed consent.
Exclusion Criteria:
- Patients with severe heart failure or severe pulmonary disease.
- Patients with a presence or history of brain tumors or cerebrovascular accidents (CVA/stroke).
- Patients with impaired cooperation or cognitive dysfunction (e.g., dementia, delirium, Alzheimer's disease).
- Patients with a known history or preoperative prediction of a difficult airway.
- Patients with a known allergy to the monitoring sensor materials.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Group M (Manual Ventilation)
Following the standardized induction of general anesthesia (1 µg/kg fentanyl, 1 mg/kg lidocaine, 2-3 mg/kg propofol, and 0.6-1 mg/kg rocuronium), mask ventilation with 100% oxygen will be manually performed by an experienced anesthesiologist or anesthesia resident.
Manual ventilation using a reservoir bag will be maintained for 2 minutes to allow for adequate muscle relaxation prior to intubation.
|
Patients will receive manual mask ventilation with 100% oxygen using a reservoir bag.
This procedure will be performed by an experienced anesthesiologist or anesthesia resident for 2 minutes following the administration of induction agents, allowing for adequate muscle relaxation prior to endotracheal intubation.
|
|
Experimental: Group A (AutoFlow Ventilation)
Following the same standardized general anesthesia induction protocol, mask ventilation with 100% oxygen will be mechanically delivered by the anesthesia workstation for 2 minutes.
The device will be set to deliver a tidal volume (VT) of 6 mL/kg based on the patient's ideal body weight, a respiratory rate of 12 breaths/minute, a peak inspiratory pressure limit of 30 cmH₂O, and a Positive End-Expiratory Pressure (PEEP) of 5 cmH₂O.
|
Patients will receive mask ventilation delivered mechanically by the anesthesia workstation.
The device will provide 100% oxygen for 2 minutes following the administration of induction agents.
The ventilator settings will be standardized to an AutoFlow mode with a tidal volume (VT) of 6 mL/kg (based on ideal body weight), a respiratory rate of 12 breaths/minute, a peak pressure limit of 30 cmH₂O, and a Positive End-Expiratory Pressure (PEEP) of 5 cmH₂O
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Cerebral Regional Oxygen Saturation (s-rSO2)
Periodo de tiempo: Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Bilateral cerebral regional oxygen saturation will be continuously measured using a Near-Infrared Spectroscopy (NIRS) device (INVOS™ oximeter) with sensors placed on the right and left frontal regions.
The changes in s-rSO2 values will be recorded to evaluate the impact of manual versus AutoFlow mask ventilation during the induction of general anesthesia.
|
Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Peripheral (Somatic) Regional Oxygen Saturation (p-rSO2)
Periodo de tiempo: Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Bilateral peripheral regional oxygen saturation will be measured using NIRS sensors placed on the volar surfaces of the right and left forearms to evaluate tissue oxygen delivery and peripheral perfusion.
|
Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
|
Mean Arterial Pressure (MAP)
Periodo de tiempo: Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Hemodynamic stability will be evaluated by recording Mean Arterial Pressure (MAP) using standard non-invasive monitor.
Measurements will be tracked to ensure parameters remain within a ±20% margin of the baseline during induction.
|
Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
|
Peripheral Oxygen Saturation (SpO2)
Periodo de tiempo: Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Standard systemic oxygen saturation will be monitored non-invasively via pulse oximetry.
|
Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
|
End-Tidal Carbon Dioxide (EtCO2)
Periodo de tiempo: Post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
The efficacy of the mask ventilation techniques will be evaluated by recording End-Tidal Carbon Dioxide (EtCO2).
|
Post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
|
Heart Rate
Periodo de tiempo: Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Hemodynamic stability will be evaluated by recording Heart Rate (HR) using standard non-invasive monitor.
|
Baseline prior to pre-oxygenation (T1), immediately after pre-oxygenation (T2), post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
|
Peak Inspiratory Pressure (PIP)
Periodo de tiempo: Post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
The efficacy of the mask ventilation techniques will be evaluated by recording Peak Inspiratory Pressure (PIP).
|
Post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
|
Tidal Volume (VT)
Periodo de tiempo: Post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
The efficacy of the mask ventilation techniques will be evaluated by recording delivered Tidal Volume (VT).
|
Post-induction/pre-intubation following 2 minutes of mask ventilation (T3), and immediately post-intubation (T4).
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: EYÜP HORASANLI, Professor, Ankara Bilkent City Hospital Department of Anesthesiology and Reanimation
Publicaciones y enlaces útiles
Publicaciones Generales
- Burkhart CS, Rossi A, Dell-Kuster S, Gamberini M, Mockli A, Siegemund M, Czosnyka M, Strebel SP, Steiner LA. Effect of age on intraoperative cerebrovascular autoregulation and near-infrared spectroscopy-derived cerebral oxygenation. Br J Anaesth. 2011 Nov;107(5):742-8. doi: 10.1093/bja/aer252. Epub 2011 Aug 10.
- Ishiyama T, Kotoda M, Asano N, Ikemoto K, Shintani N, Matsuoka T, Matsukawa T. Effects of hyperventilation on cerebral oxygen saturation estimated using near-infrared spectroscopy: A randomised comparison between propofol and sevoflurane anaesthesia. Eur J Anaesthesiol. 2016 Dec;33(12):929-935. doi: 10.1097/EJA.0000000000000507.
- Groene P, Rapp M, Ninke T, Conzen P, Hofmann-Kiefer K. Impact of mild hypo- and hyperventilation on cerebral oxygen supply during general anesthesia. Perioper Med (Lond). 2025 Mar 17;14(1):30. doi: 10.1186/s13741-025-00517-9.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- TABED 1-26-2087
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Manual Mask Ventilation
-
Freedom Laser, Inc.CitruslabsTerminadoEnvejecimiento de la piel | Piel dañada por el solEstados Unidos
-
Vanderbilt University Medical Center4DMedicalTerminado
-
Pathway Medtech, LLC.Haku TechnologyReclutamientoApnea del sueño | Calidad de sueño | Trastorno respiratorio del sueño (SDB)Bélgica
-
University of ArkansasTerminado
-
Cairo UniversityAún no reclutando
-
Faculty of Dental Medicine for GirlsReclutamiento
-
Siperstein DermatologyTerminado
-
Cairo UniversityTerminado
-
Ann & Robert H Lurie Children's Hospital of ChicagoTerminado
-
First Affiliated Hospital of Zhejiang UniversityNingbo Medical Center Lihuili Hospital; Ruijin Hospital; Sir Run Run Shaw Hospital y otros colaboradoresReclutamientoPosición de los dispositivos supraglóticos para las vías respiratoriasPorcelana